Virtu Financial’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,748
| Closed | -$26K | – | 1537 |
|
|
2024
Q3 | $26K | Sell |
13,748
-7,222
| -34% | -$13.7K | ﹤0.01% | 1098 |
|
|
2024
Q2 | $155K | Sell |
20,970
-61,059
| -74% | -$451K | 0.01% | 765 |
|
|
2024
Q1 | $642K | Buy |
82,029
+62,459
| +319% | +$489K | 0.05% | 340 |
|
|
2023
Q4 | $99K | Buy |
+19,570
| New | +$99K | 0.01% | 1032 |
|
|
2023
Q2 | – | Sell |
-21,650
| Closed | -$205K | – | 1504 |
|
|
2023
Q1 | $205K | Sell |
21,650
-5,204
| -19% | -$49.3K | 0.02% | 738 |
|
|
2022
Q4 | $286K | Buy |
26,854
+14,264
| +113% | +$152K | 0.04% | 513 |
|
|
2022
Q3 | $93K | Sell |
12,590
-23,199
| -65% | -$171K | 0.01% | 1100 |
|
|
2022
Q2 | $172K | Buy |
35,789
+21,699
| +154% | +$104K | 0.01% | 804 |
|
|
2022
Q1 | $72K | Buy |
14,090
+70
| +0.5% | +$358 | 0.01% | 1047 |
|
|
2021
Q4 | $84K | Buy |
+14,020
| New | +$84K | 0.01% | 1198 |
|
|
2021
Q1 | – | Sell |
-27,524
| Closed | -$215K | – | 1585 |
|
|
2020
Q4 | $215K | Buy |
+27,524
| New | +$215K | 0.02% | 812 |
|
|
2020
Q3 | – | Sell |
-22,287
| Closed | -$235K | – | 1040 |
|
|
2020
Q2 | $235K | Buy |
+22,287
| New | +$235K | 0.03% | 650 |
|
|
2019
Q4 | $89K | Buy |
13,593
+10,151
| +295% | +$66.5K | 0.01% | 1103 |
|
|
2019
Q3 | $24K | Buy |
3,442
+1,035
| +43% | +$7.22K | ﹤0.01% | 1274 |
|
|
2019
Q2 | $18K | Sell |
2,407
-493
| -17% | -$3.69K | ﹤0.01% | 1338 |
|
|
2019
Q1 | $42K | Buy |
2,900
+96
| +3% | +$1.39K | ﹤0.01% | 1220 |
|
|
2018
Q4 | $33K | Sell |
2,804
-3,717
| -57% | -$43.7K | ﹤0.01% | 1308 |
|
|
2018
Q3 | $146K | Buy |
6,521
+3,311
| +103% | +$74.1K | 0.01% | 1130 |
|
|
2018
Q2 | $62K | Buy |
3,210
+2,698
| +527% | +$52.1K | ﹤0.01% | 1719 |
|
|
2018
Q1 | $6K | Sell |
512
-2,750
| -84% | -$32.2K | ﹤0.01% | 1863 |
|
|
2017
Q4 | $65K | Buy |
3,262
+1,870
| +134% | +$37.3K | ﹤0.01% | 2020 |
|
|
2017
Q3 | $24K | Buy |
+1,392
| New | +$24K | ﹤0.01% | 2316 |
|